ERMEZA Trademark

Trademark Overview

On Monday, March 9, 2020, a trademark application was filed for ERMEZA with the United States Patent and Trademark Office. The USPTO has given the ERMEZA trademark a serial number of 88826046. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Mylan Pharmaceuticals, Inc.. The ERMEZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of thyroid disorders
ermeza

General Information

Serial Number88826046
Word MarkERMEZA
Filing DateMonday, March 9, 2020
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7012836
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of thyroid disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 13, 2020
Primary Code005
First Use Anywhere DateTuesday, December 13, 2022
First Use In Commerce DateTuesday, December 13, 2022

Trademark Owner History

Party NameMylan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, January 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 20, 2022USE AMENDMENT FILED
Sunday, January 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 20, 2022TEAS STATEMENT OF USE RECEIVED
Friday, September 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 31, 2022SOU EXTENSION 4 GRANTED
Wednesday, August 31, 2022SOU EXTENSION 4 FILED
Wednesday, August 31, 2022TEAS EXTENSION RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 28, 2022SOU EXTENSION 3 GRANTED
Monday, February 28, 2022SOU EXTENSION 3 FILED
Monday, February 28, 2022TEAS EXTENSION RECEIVED
Thursday, September 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 31, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 31, 2021SOU EXTENSION 2 FILED
Tuesday, August 31, 2021TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021SOU EXTENSION 1 GRANTED
Friday, February 26, 2021SOU EXTENSION 1 FILED
Friday, February 26, 2021TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 17, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2020ASSIGNED TO EXAMINER
Friday, March 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 12, 2020NEW APPLICATION ENTERED

Related Keywords

ermeza disorders thyroid treatment preparations pharmaceutical